V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Novo Nordisk A/S stake
total: 130
Dodge & Cox Stock Fund NVO trades
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Dodge & Cox Stock Fund holds 15,240,800 Novo Nordisk A/S (NVO) shares with a market value of roughly $560.10M accounting for 0.49% of the overall portfolio. To date, the estimated cost basis is nearly $36.75 for "buy" trades. Dodge & Cox Stock Fund first purchased NVO in 2026 Q1, initially acquiring about 15.24M shares.
When did Dodge & Cox Stock Fund buy Novo Nordisk A/S (NVO)?
Dodge & Cox Stock Fund first invested in Novo Nordisk A/S (NVO) in 2026 Q1 at the reported quarter-end price of $36.75 per share.
What's the cost basis of Dodge & Cox Stock Fund's NVO stake?
The estimated cost basis for Novo Nordisk A/S (NVO) stake is around $36.75 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $36.75
Dodge & Cox Stock Fund's historical trades in Novo Nordisk A/S
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.49%
|
15,240,800
|
$36.75
|
$560,099,400
|
new
|
+0.49%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.